index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

Chargement de la page

 

NOTICES

148

 

 

MOTS CLES

Biomarkers Angiotensin-converting enzyme inhibitors Graft-versus-host disease Biological Therapy Bacterial Ethics Antibiotic misuse Pharmaco-Épidémiologie Albinism Endocrine toxicity Spondylitis BTK protein Atrial fibrillation Immunotherapy Systematic review Angiotensin receptor blockers Network meta-analysis Antimicrobiens Access to care Biologic drug Cardiomyopathy Adverse side effects Psoriatic arthritis Biologic ArtThese Bacterial rhinosinusitis Immune checkpoint inhibitors Beta-lactam antibiotics Ustekinumab Burden Vigibase® Cardiotoxicity Pharmacoepidemiology Antibiotic resistance Abus d'antibiotiques Anti-Bacterial Agents Pregnancy Spondyloarthritis Epidemiology Anxiety Prostate cancer Infliximab Antibiotics Auto-Diagnostic Autoimmunity Apremilast Sipuleucel-T Stability Arthritis Anticancer drugs Axial spondyloarthritis Antimicrobial resistance Etanercept Meta-Analysis Anti-HCV Direct Acting Antivirals DAA Alitretinoin Immune-related adverse events Anxiété Auto-immune hepatitis Cardio-oncology Alcohol Quality of life Biomédicaments Atopic dermatitis Dermatology Psoriasis Amyloidosis Azathioprine Autoimmune diseases Biosimilar Pharmaceuticals Primary adrenal insufficiency Anti-TNF Pharmacovigilance Adolescent Cancer Addiction Antimicrobials Drug survival Arrhythmia Ankylosing spondylitis Acute Myeloid Leukaemia AML Adalimumab Drug reaction Intensive care Apre-milast Sacroiliitis Management Aging Treatment Antimicrobial Stewardship Placebo COVID-19 Ankylosing ASDAS Biological therapy Glucocorticoids Méta-Analyse Biologic therapy Biologics Accelerometer

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS